Q4 2024 Earnings Call Transcript February 13, 2025 Vanda Pharmaceuticals Inc. beats earnings expectations. Reported EPS is ...

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

Novo Nordisk shares dropped due to CagriSema trial results but have long-term upside. Learn why NVO stock is a Strong Buy ...

Investors are undervaluing promising drug candidates on the horizon for the two pharma giants, write Yale SOM’s Jeffrey ...

Finding stocks with the potential to double in just three years is no easy feat, even in this bull market. Plenty of ...

The 63-year-old CEO of Life Time Fitness says people always want to know his workout and supplement prescription. Here's how ...

Welcome to the Merck & Company Q4 sales and earnings conference call. [Operator instructions] This call is being recorded.

Taking a compounded GLP-1 medication isn’t the same thing as your pharmacy filling the cheaper, generic version of a drug your doctor prescribed. Though compounded semaglutide, for example ...

Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're about to lose access.

Q3 2024 results showed net income of $45.9 million, up 71% year-over-year, along with EBITDA of $119.1 million, up 55% year-over-year. Gross profit also rose to $286 million. GLP increased its ...

I'm broadly encouraged, although I wanted to hear more about the three GLP-1 agonist assets ... but some face patent expirations in the near-to-medium term, while other, newer products are ...

Global Partners LP (GLP) shares soared 6.8% in the last trading ... This compares to the stock's 14.1% gain over the past four weeks. The units’ surge can be attributed to strategic development ...